Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Br J Haematol ; 201(6): 1153-1158, 2023 06.
Article in English | MEDLINE | ID: mdl-36974355

ABSTRACT

Haematopoietic stem cell reinjection may be a curative option for poor graft function after haematopoietic stem cell transplantation; however, literature supporting its use remains limited. We conducted a multicentre retrospective study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy, including 55 patients. We demonstrated response rates of nearly 40% and two-year survival of more than 60% in the context of an otherwise deadly complication and we observed that the timing of injection and the degree of cytopenia are strongly associated with outcomes. This study shows the feasibility of the procedure informing on its epidemiology, outcomes and prognostic factors, setting the stage for future guidelines.


Subject(s)
Bone Marrow Transplantation , Hematopoietic Stem Cell Transplantation , Humans , Retrospective Studies , Societies, Medical , Hematopoietic Stem Cell Transplantation/adverse effects , Cell- and Tissue-Based Therapy
2.
Enferm. univ ; 15(2): 159-171, abr.-jun. 2018. tab, graf
Article in Spanish | LILACS-Express | LILACS, BDENF - Nursing | ID: biblio-953233

ABSTRACT

Objetivo: Determinar los factores asociados al consumo de tabaco en los estudiantes de la Licenciatura en Enfermería de la Universidad Autónoma del Estado de Morelos. Métodos: Estudio transversal realizado en 481 estudiantes que completaron un cuestionario autoaplicado con características sociodemográficas, consumo de tabaco, actitudes y conocimientos acerca del tabaquismo. Los factores asociados se analizaron con un modelo de regresión logística múltiple. Resultados: La prevalencia de fumadores activos fue de 42.4%. Se presenta mayor prevalencia en estudiantes del primer año (44.3%), que en los de cuarto año (13.9%) de la carrera. Los factores asociados al consumo de tabaco fueron el ser hombre (OR = 1.7; IC 95% (1.0 - 3.0)), ver cigarros sueltos a la venta (OR = 9.4; IC 95% (3.8 - 23.0)), que todos los amigos fumen (OR = 6.0; IC 95% (1.3-27.7)), no estar de acuerdo con prohibiciones de publicidad, así como con lugares para no fumar (OR = 3.2; IC 95% (3.0-5.2)) y cuyos padres no saben si ellos fuman (OR = 6.9; IC 95% (3.2 - 14.6)). Conclusiones: Al avanzar el estudiante en su formación académica se disminuye el consumo de tabaco. Se recomienda la incorporación de temas específicos sobre los efectos del consumo de tabaco en la salud en los contenidos de las asignaturas del programa de Licenciatura en Enfermería, así como la capacitación de los estudiantes en programas de prevención, control y cesación del tabaquismo.


Objective: To determine factors associated with tobacco use among students in the baccalaureate nursing program of the State of Morelos Autonomous University. Methods: This a transversal study with 481 students who answered a self-administered questionnaire on issues of social and demographical characteristics and attitudes and knowledge towards tobacco use. Associated factors were analyzed through a multiple logistic regression model. Results: The overall active smoking prevalence was 42.2%. A higher figure was found in the first year students in comparison to senior students (44.3% vs 13.9%). Some associated factors were: being male (OR = 1.7; CI 95% (1.0 - 3.0)); watching cigarettes being sold (OR = 9.3; CI 95% (3.8 - 23.0)); having all friends being smokers (OR = 6.0; CI 95% (1.3 - 27.7)); being in disagreement with prohibition publicity and smoking-banned places (OR = 3.2; CI 95% (3.0 - 5.2)); and having parents unaware of their sons' smoking habits (OR = 6.9; CI 95% (3.3 - 14.6)). Conclusions: Although students tend to decrease their tobacco use while they progress along their careers, it is recommended to incorporate into nursing baccalaureate programs diverse topic discussions on the health impacts from tobacco smoking in order to train the students in its prevention, control, and withdrawal.


Objetivo: Determinar os fatores associados ao consumo de tabaco nos estudantes da Licenciatura de Enfermagem da Universidad Autónoma del Estado de Morelos. Métodos: Estudo transversal realizado em 481 estudantes que completaram um questionário auto-aplicado com caraterísticas sociodemográficas, consumo de tabaco, atitudes e conhecimentos acerca do tabagismo. Os fatores associados analisaram-se com um modelo de regressão logística múltipla. Resultados: A prevalência de fumadores ativos foi de 42.4%. Apresenta-se maior prevalência em estudantes do primeiro ano (44.3%), quanto nos de quarto ano (13.9%) da carreira. Os fatores associados ao consumo de tabaco foram: o ser homem (OR = 1.7; IC 95% (1.0-3.0)), ver cigarros fracionados à venda (OR = 9.3; IC 95% (3.8 - 23.0)), que todos os amigos fumem, (OR = 6.0; IC 95% (1.3-27.7)), não concordar com proibições de publicidade, assim como com lugares para não fumantes (OR = 3.2; IC 95% (3.0 - 5.2)) e cujos pais não sabem que eles fumam (OR = 6.9; IC 95% (3.3 - 14.6)). Conclusões: Ao avançar o estudante em sua formação académica diminui o consumo de tabaco. Recomenda-se a incorporação de temas específicos sobre os efeitos do consumo de tabaco na saúde dentro dos conteúdos das disciplinas do programa de Licenciatura em Enfermagem, assim como o treinamento dos estudantes em programas de prevenção, controle e suspensão de tabagismo.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Students, Nursing , Knowledge , Tobacco Use
4.
Ann Oncol ; 28(9): 2191-2198, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28911060

ABSTRACT

BACKGROUND: Fludarabine/busulfan-based conditioning regimens are widely used to perform allogeneic stem-cell transplantation (allo-SCT) in high-risk non-Hodgkin lymphoma (NHL) patients. The impact of the dose intensity of busulfan on outcomes has not been reported yet. PATIENTS AND METHODS: This was a retrospective with the aim to compare the outcomes of NHL patients who received before allo-SCT a fludarabine/busulfan conditioning regimen, either of reduced intensity (FB2, 2 days of busulfan at 4 mg/kg/day oral or 3.2 mg/kg/day i.v.) (n = 277) or at a myeloablative reduced-toxicity dose (FB3/FB4, 3 or 4 days of busulfan at 4 mg/kg/day oral or 3.2 mg/kg/day i.v.) (n = 101). RESULTS: In univariate analysis, the 2-year overall survival (FB2 66.5% versus 60.3%, P = 0.33), lymphoma-free survival (FB2 57.9% versus 49.8%, P = 0.26), and non-relapse mortality (FB2 19% versus 21.1%, P = 0.91) were similar between both groups. Cumulative incidence of grade III-IV acute graft versus host disease (GVHD) (FB2 11.2% versus 18%, P = 0.08), extensive chronic GVHD (FB2: 17.3% versus 10.7%, P = 0.18) and 2-year GVHD free-relapse free survival (FB2: 44.4% versus 42.8%, P = 0.38) were also comparable. In multivariate analysis there was a trend for a worse outcome using FB3/FB4 regimens (overall survival: HR 1.47, 95% CI: 0.96-2.24, P = 0.08; lymphoma-free survival: HR: 1.43, 95% CI: 0.99-2.06, P = 0.05; relapse incidence: HR 1.54; 95% CI: 0.96-2.48, P = 0.07). These results were confirmed using a propensity score-matching strategy. CONCLUSION: We conclude that reduced toxicity myeloablative conditioning with fludarabine/busulfan does not improve the outcomes compared with reduced-intensity conditioning in adults receiving allo-SCT for NHL.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Busulfan/administration & dosage , Hematopoietic Stem Cell Transplantation/adverse effects , Lymphoma, Non-Hodgkin/therapy , Transplantation Conditioning , Vidarabine/analogs & derivatives , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Female , Graft vs Host Disease , Humans , Lymphoma, Non-Hodgkin/drug therapy , Male , Middle Aged , Retrospective Studies , Survival Analysis , Vidarabine/administration & dosage , Young Adult
5.
Bone Marrow Transplant ; 52(10): 1428-1435, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28650455

ABSTRACT

Unrelated cord blood transplantation (UCBT) after a reduced intensity conditioning regimen (RIC) has extended the use of UCB in elderly patients and those with co-morbidities without an HLA-identical donor, although post-transplant relapse remains a concern in high-risk acute myeloid leukemia (AML) patients. HLA incompatibilities between donor and recipient might enhance the alloreactivity of natural killer (NK) cells after allogeneic hematopoietic stem-cell transplantation (HSCT). We studied the reconstitution of NK cells and KIR-L mismatch in 54 patients who underwent a RIC-UCBT for AML in CR in a prospective phase II clinical trial. After RIC-UCBT, NK cells displayed phenotypic features of both activation and immaturity. Restoration of their polyfunctional capacities depended on the timing of their acquisition of phenotypic markers of maturity. The incidence of treatment-related mortality (TRM) was correlated with low CD16 expression (P=0.043) and high HLA-DR expression (P=0.0008), whereas overall survival was associated with increased frequency of NK-cell degranulation (P=0.001). These features reflect a general impairment of the NK licensing process in HLA-mismatched HSCT and may aid the development of future strategies for selecting optimal UCB units and enhancing immune recovery.


Subject(s)
Cord Blood Stem Cell Transplantation , Killer Cells, Natural/immunology , Leukemia, Myeloid, Acute/immunology , Recovery of Function/immunology , Registries , Transplantation Conditioning , Adult , Allografts , Disease-Free Survival , Female , Humans , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/therapy , Male , Middle Aged , Prospective Studies , Survival Rate
6.
Bone Marrow Transplant ; 52(8): 1120-1125, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28530668

ABSTRACT

Relapse remains the most common cause of treatment failure in patients receiving autologous stem cell transplantation (ASCT) for follicular lymphoma (FL). The aim of this study was to evaluate the effect of adding radioimmunotherapy or rituximab (R) to BEAM (carmustine, etoposide, ara-c, melphalan) high-dose therapy for ASCT in patients with relapsed FL. Using the European Society for Blood and Marrow Transplantation registry, we conducted a cohort comparison of BEAM (n=1973), Zevalin-BEAM (Z-BEAM) (n=207) and R-BEAM (n=179) and also a matched-cohort analysis of BEAM vs Z-BEAM including 282 and 154 patients, respectively. BEAM, Z-BEAM and R-BEAM groups were well balanced for age, time from diagnosis to ASCT and disease status at ASCT. The cumulative incidences of relapse (IR) at 2 years were 34, 34 and 32% for Z-BEAM, R-BEAM and BEAM, respectively. By multivariate analysis, there were no significant differences with Z-BEAM or R-BEAM compared with BEAM for IR, non-relapse mortality, event-free survival or overall survival. With the caveat that the limitations of registry analyses have to be taken into account, this study does not support adding radioimmunotherapy or R to BEAM in ASCT for relapsed FL. However, we cannot rule out the existence a particular subset of patients who could benefit from Z-BEAM conditioning that cannot be identified in our series, and this should be tested in a randomized trial.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Hematopoietic Stem Cell Transplantation/methods , Lymphoma, Follicular/therapy , Radioimmunotherapy/methods , Adult , Aged , Carmustine/therapeutic use , Case-Control Studies , Combined Modality Therapy/methods , Cytarabine/therapeutic use , Etoposide/therapeutic use , Female , Hematopoietic Stem Cell Transplantation/mortality , Humans , Lymphoma, Follicular/mortality , Male , Melphalan/therapeutic use , Middle Aged , Retrospective Studies , Rituximab/therapeutic use , Survival Analysis , Transplantation, Autologous , Young Adult
7.
Bone Marrow Transplant ; 51(7): 928-32, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27042842

ABSTRACT

This report retrospectively analyzed the outcome of 91 patients aged 60 years or older with refractory/relapsed (R/R) classical Hodgkin's lymphoma (cHL) who underwent autologous stem cell transplantation (ASCT) between 1992 and 2013 and were reported to the French Society of Bone Marrow Transplantation and Cell Therapies registry. The median age at transplant was 63 years. The majority of patients exhibited disease chemosensitivity to salvage treatment (57 complete responses, 30 partial responses, 1 progressive disease and 3 unknown). The most frequent conditioning regimen consisted of BCNU, cytarabine, etoposide, melphalan (BEAM) chemotherapy (93%). With a median follow-up of 54 months, 5-year estimates of overall survival (OS) and progression free survival (PFS) for the entire group were 67 and 54%, respectively. Despite the missing data, in univariate analysis, the number of salvage chemotherapy lines (1-2 versus ⩾3) significantly influenced the OS, unlike the other prognostic factors (stage III-IV at relapse, disease status before ASCT and negative positron emission tomography (PET) scan) encountered in younger patients. In spite of its limitations, this retrospective study with a long-term follow-up suggests that ASCT is a valid treatment option for chemosensitive R/R cHL in selected elderly patients, with an acceptable rate of toxicity.


Subject(s)
Hematopoietic Stem Cell Transplantation/methods , Hodgkin Disease/therapy , Salvage Therapy/methods , Age Factors , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Female , Follow-Up Studies , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/mortality , Hodgkin Disease/mortality , Humans , Male , Middle Aged , Retrospective Studies , Salvage Therapy/mortality , Survival Analysis , Transplantation, Autologous
8.
Bone Marrow Transplant ; 51(9): 1184-90, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27111043

ABSTRACT

Poly-chemotherapy plus rituximab followed by autologous stem cell transplantation (auto-SCT) is standard care for untreated young patients with mantle cell lymphoma (MCL). Despite this intensive treatment, transplant patients remain highly susceptible to relapse over time. The French SFGM-TC performed a national survey on reduced-intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) for fit relapsed/refractory patients who failed after auto-SCT (n=106). Median times of relapse after auto-SCT, and from auto-SCT to RIC-allo-SCT were 28 months and 3.6 years, respectively. Sixty per cent of patients received at least three lines of treatment before RIC-allo-SCT. Conditioning regimens for RIC-allo-SCT were heterogeneous. Twenty patients experienced grade III/IV aGvHD, extensive cGvHD was reported in 28 cases. Median follow-up after RIC-allo-SCT was 45 months. Median PFS after RIC-allo-SCT was 30.1 months and median overall survival was 62 months. Treatment-related mortality (TRM) at 1 year and 3 years were estimated at 28% and 32%, respectively. A total of 52 patients died; major causes of death were related to toxicity (n=34) and MCL (n=11). Patients in good response before RIC-allo-SCT experienced a better PFS and OS. Our work highlights the need for new RIC-allo-SCT MCL-tailored approaches to reduce TRM, and early and late relapse.


Subject(s)
Hematopoietic Stem Cell Transplantation/methods , Lymphoma, Mantle-Cell/therapy , Salvage Therapy/methods , Transplantation, Homologous , Adult , Aged , Female , France , Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/mortality , Humans , Lymphoma, Mantle-Cell/complications , Lymphoma, Mantle-Cell/mortality , Male , Middle Aged , Salvage Therapy/mortality , Surveys and Questionnaires , Survival Analysis , Transplantation Conditioning/methods , Transplantation, Autologous/adverse effects , Transplantation, Autologous/mortality , Transplantation, Homologous/adverse effects , Transplantation, Homologous/methods , Transplantation, Homologous/mortality
9.
Bone Marrow Transplant ; 51(2): 256-61, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26569092

ABSTRACT

Epidemiology and prognosis of complications related to allogeneic hematopoietic stem cell transplant (HSCT) recipients requiring admission to intensive care unit (ICU) have not been reassessed precisely in the past few years. We performed a retrospective single-center study on 318 consecutive HSCT patients (2009-2013), analyzing outcome and factors prognostic of ICU admission. Among these patients, 73 were admitted to the ICU. In all, 32 patients (40.3%) died in ICU, 46 at hospital discharge (63%) and 61 (83.6%) 1 year later. Survivors had a significantly lower sequential organ failure assessment (SOFA) score, serum lactate and bilirubin upon ICU admission. Catecholamine support, mechanical ventilation (MV) and/or renal replacement therapy during ICU stay, a delayed organ support and an active graft versus host disease (GvHD) significantly worsen the outcome. By multivariate analysis, the worsening of SOFA score from days 1 to 3, the need for MV and the occurrence of an active GvHD were predictive of mortality. In conclusion, the incidence of HSCT-related complications requiring an admission to an ICU was at 22%, with an ICU mortality rate of 44%, and 84% 1 year later. A degradation of SOFA score at day 3 of ICU, need of MV and occurrence of an active GvHD are main predictive factors of mortality.


Subject(s)
Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Intensive Care Units , Adult , Allografts , Disease-Free Survival , Female , Follow-Up Studies , Graft vs Host Disease/mortality , Graft vs Host Disease/therapy , Humans , Male , Middle Aged , Risk Factors , Survival Rate
11.
Ann Oncol ; 26(1): 193-198, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25361987

ABSTRACT

BACKGROUND: Patients with advanced B-cell non-Hodgkin's lymphoma (NHL) refractory to initial chemotherapy or relapsing after autologous stem-cell transplantation have a poor prognosis. Allogeneic stem-cell transplantation after reduced-intensity conditioning (RIC) regimen can be a therapeutic option. However, the high incidence of relapse remains a challenging issue. We speculated that the incorporation of (90)Y-Ibritumomab tiuxetan into a fludarabine-based RIC regimen would improve the lymphoma control without overwhelming toxicity. Our aim was to evaluate the safety of (90)Y-Ibritumomab tiuxetan in association with such a regimen in a prospective multicenter phase II trial. PATIENTS AND METHODS: Thirty-one patients with advanced lymphoma from five distinct institutions were included between February 2008 and October 2010. Thirty patients in complete or partial response after failure of a median of 3 (range, 2-4) previous chemotherapy regimens including autologous transplant in 29 were evaluable for nonrelapse mortality (NRM) at day 100 post-transplant that was the primary end point. RESULTS: With a median follow-up of 32 months (range, 29-60 months), the 2-year event-free and overall survivals of the whole study group were both 80% [95 confidence interval (CI) 60.8% to 90.5%). The 100-day and 2-year post-transplant cumulative incidences of NRM were 3.3% (95% CI 0.2% to 14.9%) and 13.3% (95% CI 5.4% to 33.2%), respectively. The 2-year cumulative incidence of relapse was 6.7% (95% CI 1.7% to 25.4%). The cumulative incidences of grade II-IV and extensive chronic graft-versus-host disease were 27% and 14%, respectively. CONCLUSIONS: For chemosensitive advanced high-risk B-cell lymphoma, the addition of (90)Y-Ibritumomab tiuxetan to a RIC regimen based on fludarabine, busulfan and antithymocyte globulin followed by allogeneic transplant is safe and highly effective. clinicaltrials.gov: NCT00607854.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antilymphocyte Serum/therapeutic use , Busulfan/therapeutic use , Lymphoma, B-Cell/drug therapy , Vidarabine/analogs & derivatives , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Disease-Free Survival , Female , Graft vs Host Disease , Humans , Lymphoma, B-Cell/surgery , Male , Middle Aged , Neoplasm Recurrence, Local , Prospective Studies , Salvage Therapy , Stem Cell Transplantation , Transplantation Conditioning , Transplantation, Homologous , Treatment Outcome , Vidarabine/therapeutic use
12.
Eur J Clin Microbiol Infect Dis ; 31(2): 161-7, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21611869

ABSTRACT

Posaconazole (PCZ) is given at 200 mg three times daily as a fungal prophylaxis in neutropenic hematologic malignancy patients. A relationship between exposure, plasma concentration, and efficacy is suggested. The objectives of this prospective study were to analyze the PCZ plasma concentration in hematology adults at high risk of developing invasive fungal infections (IFIs), and factors that could have an impact on the PCZ plasma concentration. PCZ plasma concentrations were measured after 2, 7, 10, 14, and 21 days of PCZ prophylaxis. Factors such as gender, age, body weight, posology, treatment duration, mucositis, proton pump inhibitor (PPI) use, and food intake were studied. Sixty-three patients were included, with a median age of 52 years (range 17-70) and a median weight of 75 kg (range 47-150). The median PCZ plasma concentration of the 63 patients ranged from 0.42 to 0.48 mg/L. At day 2, 30% of PCZ plasma concentration were under 0.35 mg/L, and at day 7, 74% were <0.70 mg/L. PCZ plasma concentrations were not affected by gender, age, body weight, or treatment duration. We found that food intake had a high influence on PCZ plasma concentrations (p = 0.0049). PCZ was well tolerated. One patient has developed a probable IFI, probably related to a low exposure to PCZ. PCZ therapeutic drug monitoring (TDM) is essential in order to early detect patients with low concentrations, to assess the etiology of such results, and to decide on the treatment strategy to apply.


Subject(s)
Antifungal Agents/pharmacokinetics , Antifungal Agents/therapeutic use , Drug Monitoring/methods , Eating , Hematologic Neoplasms/complications , Mycoses/prevention & control , Triazoles/pharmacokinetics , Triazoles/therapeutic use , Adolescent , Adult , Aged , Antifungal Agents/administration & dosage , Antifungal Agents/adverse effects , Antineoplastic Agents/therapeutic use , Chemoprevention , Female , Hematologic Neoplasms/drug therapy , Humans , Male , Middle Aged , Triazoles/administration & dosage , Triazoles/adverse effects , Young Adult
13.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 35(6): 207-214, nov. 2008. ilus
Article in Es | IBECS | ID: ibc-70367

ABSTRACT

La principal causa de mortalidad del carcinoma mamario es el desarrollo de metástasis producto de la invasión de células tumorales que viajan por la circulación sanguínea o linfática. Con el objetivo de detectar células tumorales circulantes en pacientes con cáncer de mama se han utilizado diversos marcadores. Los métodos utilizados principalmente son los inmunológicos y los basados en la detección de la expresión de los marcadores por métodos de biología molecular, como la reacción en cadena de la polimerasa (PCR) y la transcripción reversa (RT)-PCR. La proteína denominada mamaglobina A (MGA) es parte de la familia de las secretoglobinas. La expresión de MGA es altamente específica del epitelio mamario normal y neoplásico, y se utiliza para detectar células tumorales circulantes en pacientes con cáncer de mama mediante RT-PCR. No se ha detectado MGA en muestras de sangre de individuos sanos. Distintos estudios no encontraron una asociación significativa entre la detección de MGA y la presencia de metástasis ganglionar axilar, el tamaño tumoral, el grado histológico tumoral y la presencia de receptores hormonales en el tumor. Se ha sugerido que la detección de la MGA sería un marcador pronóstico independiente de la enfermedad. La determinación de MGA en sangre periférica de pacientes con carcinoma mamario, principalmente en las pacientes sin evidencia de metástasis, podría brindar un pronóstico de la evolución de la enfermedad y, tal vez, contribuir en la elección del tratamiento que hay que seguir para prevenir su recidiva (AU)


The main cause of mortality in breast carcinoma is the development of metastases resulting from the invasion of tumor cells that travel by blood or lymphatic circulation. To detect circulating tumor cells in patientswith breast cancer, diverse markers have been used. The methods applied are mainly immunological or based on the detection of marker expression by molecular biology techniques, such as polymerase chain reaction (PCR) and reverse transcription (RT)-PCR.T he protein known as mammaglobin A (MGA) is part of the secretoglobin family. MGA expression is highly specific to normal and neoplastic breast epithelia and is used to detect circulating tumor cells in patientswith breast cancer by means of RT-PCR. MGA has not been detected in peripheral blood samples from healthy individuals. Several studies found no significant associations between MGA detection and the presence of axillary lymph node metastases, tumor size, histological grade and the presence of hormonereceptors in the tumor.MGA detection has been suggested to be an independent prognostic marker of the disease. Determination of MGA in the blood of patients with breast carcinoma, mainly in those without evidence of metastasis, could indicate a prognosis of disease progression and could contribute to the choice of treatment to prevent tumoral recurrence (AU)


Subject(s)
Humans , Female , Adult , Middle Aged , Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Hemoglobin A/analysis , Hemoglobin A , Immunohistochemistry/methods , Biomarkers, Tumor/analysis , Biomarkers, Tumor/blood , Breast Neoplasms/blood , Neoplasms/complications , Neoplasm Metastasis/pathology
14.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 35(2): 69-70, mar. 2008. ilus
Article in Es | IBECS | ID: ibc-63011

ABSTRACT

La anomalía congénita más frecuente de la vagina es el himen imperforado, aunque es una patología poco común puede asociarse a otras malformaciones urogenitales. Generalmente cursa de forma silente hasta que con la menarquia se produce acumulación de sangre en genitales internos. La sospecha diagnóstica se establece tras la realización de anamnesis y exploración detalladas, utilizando técnicas de imagen para su confirmación a la vez que descartar o no patología asociada. Se presenta el caso clínico de una adolescente con una masa abdominal debida a un hematocolpos como consecuencia de una imperforación himeneal (AU)


Although unusual, imperforate hymen is the most common congenital vaginal abnormality and is often associated with other urinogenital malformations. This anomaly is usually unnoticed until menstrual blood accumulates in the vagina. Diagnosis is established after study of the patient's case history and detailed physical examination. Imaging studies will confirm the diagnosis and establish or exclude the presence of associated malformations. We report the case of an adolescent girl who presented with an abdominal mass due to a hematocolpos resulting from imperforate hymen (AU)


Subject(s)
Humans , Female , Adolescent , Hematocolpos/diagnosis , Hematocolpos/surgery , Hymen/abnormalities , Hymen/surgery , Abdominal Pain/diagnosis , Abdominal Pain/etiology , Diagnostic Imaging/methods , Vagina/abnormalities , Vagina/surgery , Abdomen , Medical History Taking/methods , Diagnostic Imaging
15.
Rev. Asoc. Esp. Espec. Med. Trab ; 16(2): 78-79, jun. 2007. ilus
Article in Spanish | IBECS | ID: ibc-89167

ABSTRACT

La onicocriptosis es una patología frecuente también en el medio labora. Se describen las distitnas posibilidades de tratamiento. Se analizan los tratamientos conservadores frente a los tratamientos quirúrgicos. Los tratamientos conservadores son efectivos, de bajo coste y sin contraindicaciones (AU)


Ingrowing toenails is a often patology in the laboral enviroment. The possible diferent treatments are describe, The conservative treatment are analised compare to quirurgical treatment. The consevative treatment are efective, low cost and without contraindications (AU)


Subject(s)
Humans , Nails, Ingrown/therapy , Occupational Diseases/therapy , Anti-Bacterial Agents/therapeutic use
16.
Bone Marrow Transplant ; 38(4): 275-84, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16883311

ABSTRACT

The use of a combination of G-CSF and GM-CSF versus G-CSF alone, after cyclophosphamide (4 g/m2) was compared in two randomized phase III studies, including 120 patients. In study A, 60 patients received 5 x 2 microg/kg/day of G-CSF and GM-CSF compared to 5 mug/kg/day of G-CSF. In study B, 60 patients received 2.5 x 2 microg/kg/day G-CSF and GM-CSF compared to G-CSF alone (5 microg/kg/day). With the aim to collect at least 5 x 10(6)/kg CD34 cells in a maximum of three large volume leukapherises (LK), 123 LK were performed in study A, showing a significantly higher number of patients reaching 10 x 10(6)/kg CD34 cells (21/29 in G+GM-CSF arm vs 11/27 in G-CSF arm, P=0.00006). In study B, 109 LK were performed, with similar results (10/27 vs 15/26, P=0.003). In both the study, the total harvest of CD34 cells/kg was twofold higher in G-CSF plus GM-CSF group (18.3 x 10(6) in study A and 15.85 x 10(6) in study B) than in G-CSF group (9 x 10(6) in study A and 8.1 x 10(6) in study B), a significant difference only seen in multiple myeloma, with no significant difference in terms of mobilized myeloma cells between G-CSF and GM-CSF groups.


Subject(s)
Cyclophosphamide/administration & dosage , Granulocyte Colony-Stimulating Factor/administration & dosage , Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage , Leukapheresis/methods , Adult , Aged , Antigens, CD34 , Drug Therapy, Combination , Female , Filgrastim , Humans , Leukapheresis/standards , Leukocyte Count , Male , Middle Aged , Multiple Myeloma/pathology , Peripheral Blood Stem Cell Transplantation/methods , Recombinant Proteins/administration & dosage
17.
Ann Fr Anesth Reanim ; 23(4): 339-43, 2004 Apr.
Article in French | MEDLINE | ID: mdl-15120776

ABSTRACT

OBJECTIVE: We studied elderly patients admitted for hyperosmolar state (HS) to evaluate current outcome of HS and identify prognosis factors associated with mortality. STUDY DESIGN: A clinical retrospective study in an eight bed ICU. PATIENTS AND METHODS: Eighteen over 65-year-old patients admitted with a serum osmolality greater than 325 mOsm/kg were reviewed. Age, sex, diabetes mellitus, underlying medical condition, presence of an acute precipitating factor, Apache II and Glasgow scores, systolic arterial pressure, state of hydration, core temperature, heart rate, serum osmolality, creatininemia, lactatemia, plasma urea and bicarbonate, and protidemia were collected at the admission. Amount of fluid, time course of osmolality correction, length of hospitalization and mortality were recorded. All data were analyzed to identify possible correlations with patient outcome. RESULTS: Mean age: 75 +/- 11 years; sex ratio 1/2; hyperosmolar hyperglycemic states: 13 patients; hyperosmolar hypernatremic states: five patients; mean Apache II score: 18 +/- 7; Glasgow coma score: 11 +/- 3; mean osmolality: 370 +/- 25 mOsm/kg. In nine patients, infection was the precipitating factor. Five patients died (28%). At the admission, low blood pressure and high heart rate were related to mortality. During hospitalization, the occurrence of an acute cardiocirculatory failure and/or the need of mechanical ventilation significantly worsens the outcome. CONCLUSION: Our results showed that ICU mortality of HS in the elderly was at 28%. Haemodynamic state was the only factor of prognosis at the admission. Deaths were mostly related to acute respiratory and circulatory failure.


Subject(s)
Aged/physiology , Water-Electrolyte Imbalance/epidemiology , Water-Electrolyte Imbalance/therapy , APACHE , Female , Glasgow Coma Scale , Heart Rate/physiology , Humans , Hyperglycemia/complications , Hyperglycemia/physiopathology , Hypernatremia/complications , Hypernatremia/physiopathology , Hypotension/physiopathology , Infections/complications , Male , Prognosis , Respiration, Artificial , Retrospective Studies , Risk Factors , Water-Electrolyte Imbalance/mortality
18.
Int J Obes Relat Metab Disord ; 27(1): 13-8, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12532148

ABSTRACT

OBJECTIVE: To evaluate the relationship between serum leptin levels and metabolic syndrome, fasting insulin level and anthropometric index in obese pre-pubertal children. DESIGN: A cross-sectional study was carried out on obese children. SUBJECTS: A study was made of 41 obese children (aged 6-9 y) and the same number of non-obese children (control group), matched by age and sex. METHODS: Body mass index (BMI), waist/hip ratio (WHR) and blood pressure were determined in each child. Serum leptin, glucose, insulin, lipid profile, sex hormone binding globulin (SHBG), plasminogen activator inhibitor-1 (PAI-1), tissue-plasminogen activator (t-PA) and fibrinogen were all measured. RESULTS: The serum leptin level was significantly higher in obese children (15.47 vs 4.73 ng/ml). In the obese group, leptin showed a positive correlation with BMI (P<0.001), insulin (P<0.001), triglycerides (P<0.05), PAI-1 (P<0.05) and t-PA (P<0.05), and correlated negatively with SHBG (P<0.01), apolipoprotein A-I (P<0.05) and high-density lipoproteins cholesterol (HDL-C) (P<0.05). Corrected for BMI and WHR, leptin (P partial=0.002) is only an independent predictive factor for basal insulin. Using multivariant regression analysis, only insulin (P partial=0.003) and BMI (P partial=0.018) were independent predictive factors for leptin. CONCLUSION: For this age group, high leptin resistance may be another component of metabolic syndrome, and may be involved in its etiopathogenesis. The involvement of leptin in this syndrome may be indirect, modulating the insulin's action.


Subject(s)
Leptin/blood , Metabolic Syndrome/blood , Obesity/blood , Body Mass Index , Child , Cross-Sectional Studies , Female , Fibrinogen/metabolism , Humans , Insulin/blood , Male , Plasminogen Activator Inhibitor 1/metabolism , Tissue Plasminogen Activator/metabolism
19.
Rev Med Interne ; 22(10): 988-91, 2001 Oct.
Article in French | MEDLINE | ID: mdl-11695323

ABSTRACT

INTRODUCTION: Spinal cord lesions are an uncommon mode of discovering acquired immunodeficiency syndrome because they usually appear at a later stage. EXEGESIS: We report a 58-year-old patient who had a spastic paraparesia and sphincter dysfunction. The spinal cord magnetic resonance imaging showed spontaneous hypersignals on T2-weighted images at the cervical and thoracic levels, enhanced with gadolinium, and without swelling. No cause was found. The HIV serology was positive and allowed us to consider an HIV-associated myelopathy. The antiretroviral therapy led to functional recovery. CONCLUSION: An HIV serology is suggested whenever an unexplained intramedullary lesion is discovered. Indeed, the diagnosis of HIV-associated myelopathy implies a specific therapeutic approach.


Subject(s)
HIV Infections/complications , Spinal Cord Diseases/etiology , Diagnosis, Differential , HIV Infections/diagnosis , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Myelitis , Paraparesis, Spastic/etiology , Spinal Cord Diseases/pathology , Spinal Cord Diseases/virology
20.
J Agric Food Chem ; 49(11): 5646-52, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11714372

ABSTRACT

Some of the beneficial effects of moderate wine consumption may be related to the antioxidant properties of polyphenolic compounds containing tannins, flavonoids, and phenolic acids. Cellular actions have recently been reported and may involve the modulation of transcriptional factors such as AP-1 (activator protein-1), which controls the expression of various genes implicated in inflammation processes, cell differentiation, and proliferation. The aim of this study was to evaluate the modulation of AP-1 activity by the phenolic acids (gallic, caffeic, protocatechic, paracoumaric, sinapic, and ferulic acids) that are present in wine and to compare their modulating pathways to those of lipophilic or hydrophilic "chain-breaking" antioxidants (such as DL-alpha-tocopherol or trolox) vitamin C, nitric oxide, and reduced glutathione. AP-1 response was studied on a cell line (MTLN) derived from MCF-7 cells transfected with luciferase gene under TRE sequence control. After stimulation by phorbol 12-myristate 13-acetate (PMA; 100 nM, 6 h, 10(-7) M), luciferase activity was determined by a luminescence method in the presence of luciferine/coenzyme A solution using a luminometer (LKB 1251, Finland). Antioxidants to be tested were incubated with cells in the presence or absence of PMA. Stimulation with PMA resulted in an AP-1-mediated increase in luciferase gene expression corresponding to an 8-fold increase in luciferase activity. After stimulation by PMA, a dose-dependent inhibition of AP-1 was observed with the six phenolic acids in the 20 nM-20 microM concentration range: gallic acid > caffeic > protocatechic, paracoumaric, sinapic acids > ferulic acid. Inhibition was more pronounced with phenolic acids than with DL-alpha-tocopherol (IC(50) = 5 +/- 4.5 microM for gallic acid vs 85 +/- 11 microM for vitamin E). None of the hydrophilic antioxidants inhibited PMA-induced AP-1 activation. None of the antioxidants tested in the absence of PMA stimulation induced any activation or inhibition of AP-1. Our results suggest that phenolic acids may act directly on cell signaling via inhibition of AP-1 transcriptional activity. In addition to preventing LDL oxidation in the arterial wall, our observations indicate that phenolic acids have a cell-mediated capacity to prevent some of the processes involved in atherosclerosis in a plasma concentration range compatible with nutritional intakes.


Subject(s)
Antioxidants/pharmacology , Hydroxybenzoates/pharmacology , Transcription Factor AP-1/antagonists & inhibitors , Wine/analysis , Base Sequence , Cell Line , DNA Primers , Humans , Luciferases/genetics , Luminescent Measurements , Tetradecanoylphorbol Acetate/pharmacology , Transcription Factor AP-1/metabolism , alpha-Tocopherol/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...